https://www.onhealthcare.tech/p/gene-editing-has-the-science-figuredThoughts on Healthcare Markets & Technologyen2026-05-09T22:25:26+00:00Gene Editing Has the Science Figured Out and Now Needs an Entire Stack of New Business Models, Reimbursement Mechanics, and Healthcare Operating Infrastructure Before Any of This Scales to Patientshttps://www.onhealthcare.tech/p/what-the-smart-money-just-boughtThoughts on Healthcare Markets & Technologyen2026-05-09T17:30:17+00:00What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Dayshttps://www.onhealthcare.tech/p/part-ii-what-the-smart-money-justThoughts on Healthcare Markets & Technologyen2026-05-09T17:18:18+00:00Part II: What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Dayshttps://www.onhealthcare.tech/p/part-i-what-the-smart-money-justThoughts on Healthcare Markets & Technologyen2026-05-09T17:09:53+00:00Part I: What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Dayshttps://www.onhealthcare.tech/p/the-peptide-split-how-glp-1s-lutathera-f57Thoughts on Healthcare Markets & Technologyen2026-05-08T13:01:24+00:00The Peptide Split: How GLP-1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC-157, TB-500, MOTS-c, and the Wellness Grift Borrow Their Halohttps://www.onhealthcare.tech/p/the-peptide-split-how-glp-1s-lutatheraThoughts on Healthcare Markets & Technologyen2026-05-08T12:41:32+00:00The Peptide Split: How GLP-1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC-157, TB-500, MOTS-c, and the Wellness Grift Borrow Their Halo